Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. NUTX
NUTX logo

NUTX Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
192.750
Open
192.600
VWAP
188.83
Vol
101.91K
Mkt Cap
1.29B
Low
185.835
Amount
19.24M
EV/EBITDA(TTM)
5.16
Total Shares
6.88M
EV
1.54B
EV/OCF(TTM)
5.64
P/S(TTM)
1.51
Nutex Health Inc. is a healthcare management and operations company. The Company operates in three segments: the Hospital division, the Population Health Management (PHM) division, and the Real Estate division. The Hospital division owns, develops and operates healthcare models, including micro-hospitals, specialty hospitals, and hospital outpatient departments (HOPDs). This division owns and operates over 27 facilities in 12 states. In addition, it has financial and operating relationships with multiple professional entities and real estate entities. The Population Health Management division owns and operates provider networks, such as Independent Physician Associations (IPAs). Through its Management Services Organization, it provides management, administrative and other support services to its affiliated hospitals and physician groups. The Real Estate division comprises the Real Estate Entities, which owns the land and hospital buildings which are leased to its hospital entities.
Show More

Events Timeline

(ET)
2026-04-30
17:20:00
Nutex Health Reports Q1 Revenue of $216.49M
select
2026-03-06 (ET)
2026-03-06
09:00:00
Oil Prices Surge as Markets Decline Due to Geopolitical Risks
select
2026-03-06
08:10:00
Nutex Health Reports $11.8M Net Income for Q4 2025
select
2026-03-05 (ET)
2026-03-05
19:30:00
Marvell Technology Shares Rise 15% After Earnings
select
2026-03-05
18:50:00
Nutex Health Q4 Revenue $151.7M, Below Expectations
select
2026-03-05
18:50:00
Nutex Health Reports 2025 EPS of $10.48 vs. $9.69 in 2024
select
2026-03-05
18:50:00
Nutex Health Authorizes $25M Stock Repurchase Program
select

News

NASDAQ.COM
4.5
06-26NASDAQ.COM
U.S. Stocks Close Lower on Friday, Chipmakers Weigh on Market
  • Market Decline: The S&P 500 and Nasdaq 100 fell by 0.05% and 1.09% respectively on Friday, reaching two-week lows, indicating market sensitivity to the weak performance of chipmakers, which could undermine investor confidence.
  • Chipmaker Sell-off: The significant drop in Samsung Electronics and SK Hynix shares led to a more than 5% decline in South Korea's Kospi Index, triggering a global downturn in semiconductor stocks and exacerbating market uncertainty.
  • Oil Price Impact: WTI crude oil prices fell over 3% to a four-month low on Friday, which helps lower inflation expectations and supports the stock market, but also reflects potential slowdowns in global economic growth.
  • Consumer Sentiment Revision: The University of Michigan's consumer sentiment index was revised upward by 0.6 to 49.5, although still below the expected 50.0, indicating a cautious consumer outlook that may affect future spending.
NASDAQ.COM
4.5
06-26NASDAQ.COM
US Stock Market Under Pressure as Chip Stocks Plummet
  • Market Weakness: The S&P 500 and Nasdaq 100 indices fell by 0.07% and 0.75%, respectively, reaching two-week lows, indicating market sensitivity to the weak performance of chipmakers, which may lead to declining investor confidence.
  • Chip Stock Plunge: The significant sell-off of Samsung Electronics and SK Hynix caused the South Korean Kospi index to drop over 5%, triggering a global decline in chip stocks and exacerbating market uncertainty.
  • Oil Price Decline Impact: WTI crude oil prices fell by more than 3%, easing inflation expectations and supporting stocks; however, the recovery of crude exports to 75% of pre-war levels may influence future market dynamics.
  • Consumer Sentiment Revision: The University of Michigan's consumer sentiment index was revised upward to 49.5, although still below the expected 50.0, reflecting cautious consumer attitudes towards the economic outlook, which could affect retail and consumer-related stocks.
NASDAQ.COM
4.5
06-26NASDAQ.COM
US Stocks Decline as Chipmakers Weigh on Market
  • Market Decline: The S&P 500 index fell by 0.54% and the Nasdaq 100 dropped by 1.38%, both hitting two-week lows, indicating a weak market sentiment primarily driven by the poor performance of chipmakers, which significantly pressured the overall market.
  • Chipmaker Sell-off: The sharp decline in Samsung Electronics and SK Hynix led to a more than 5% drop in South Korea's Kospi index, triggering a global sell-off in chip stocks and exacerbating investor concerns regarding the tech sector.
  • Oil Price Impact: WTI crude oil prices fell by over 3% today, which not only eased inflation expectations but also lowered bond yields; however, the overall market remained under pressure due to weak stock performance.
  • Software Stock Resilience: Despite the overall market downturn, software stocks like ServiceNow and Salesforce rose by over 6% and 4% respectively, somewhat limiting the market's downside, reflecting ongoing investor confidence in the software sector.
Globenewswire
7.0
06-09Globenewswire
Nutex Health Executives Accused of Breaching Fiduciary Duties
  • Investigation Launched: Kuehn Law, PLLC is investigating whether Nutex Health, Inc. executives breached their fiduciary duties to shareholders, with allegations that could expose the company to significant legal risks.
  • False Statements Revealed: A federal securities lawsuit claims that Nutex Health failed to disclose fraudulent activities associated with its partnership with HaloMD, raising doubts about the sustainability of the company's revenues and potentially impacting the accuracy of future financial reports.
  • Internal Control Deficiencies: The company is accused of overstating its ability to remediate material weaknesses in its internal controls over financial reporting, leading to difficulties in accounting for stock-based compensation obligations and increasing the risk of delays in filing financial reports.
  • Shareholder Rights at Risk: Due to these issues, Nutex Health's business prospects were overstated, resulting in materially false and misleading public statements at all relevant times, prompting shareholders to contact legal counsel promptly to protect their rights.
NASDAQ.COM
2.0
05-04NASDAQ.COM
Nutex Health NUTX Q1 2025 Earnings Transcript
NASDAQ.COM
2.0
05-04NASDAQ.COM
Nutex Health NUTX Q2 2025 Earnings Transcript
Wall Street analysts forecast NUTX stock price to rise
2 Analyst Rating
Wall Street analysts forecast NUTX stock price to rise
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 0.000
sliders
Low
230.00
Averages
265.00
High
300.00
Current: 0.000
sliders
Low
230.00
Averages
265.00
High
300.00
B. Riley
Anderson Schock
Buy
initiated
$290
AI Analysis
2026-06-26
Reason
B. Riley
Anderson Schock
Price Target
$290
AI Analysis
2026-06-26
initiated
Buy
Reason
B. Riley analyst Anderson Schock initiated coverage of Nutex Health with a Buy rating and $290 price target. Nutex Health operates a network of micro-hospitals serving the gap between urgent care and large ERs, with an out-of-network arbitration-driven model and a new capital-light expansion strategy using sale-leasebacks to fund 3-5 annual openings, the analyst tells investors in a research note. While 2026 results are expected to reset lower due to non-recurring arbitration benefits, improving reimbursement efficiency and referral networks support a constructive long-term growth outlook, the firm says.
B. Riley
Buy
initiated
$290
2026-06-26
Reason
B. Riley
Price Target
$290
2026-06-26
initiated
Buy
Reason
B. Riley initiated coverage of Nutex Health with a Buy rating and $290 price target.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for NUTX
Unlock Now

Valuation Metrics

The current forward P/E ratio for Nutex Health Inc (NUTX.O) is 0.00, compared to its 5-year average forward P/E of -23.41. For a more detailed relative valuation and DCF analysis to assess Nutex Health Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-23.41
Current PE
0.00
Overvalued PE
72.87
Undervalued PE
-119.68

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
53.33
Current EV/EBITDA
3.77
Overvalued EV/EBITDA
157.07
Undervalued EV/EBITDA
-50.40

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
2.81
Current PS
1.35
Overvalued PS
9.59
Undervalued PS
-3.97

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

what's the best stock to buy Winner?
Intellectia · 73 candidates
Price: >= $-100.00Volume: >= -100Relative Vol: >= 1.50Moving Average Relationship: PriceAboveMA20, PriceAboveMA200Month Price Change Pct: >= $0.00Quarter Price Change Pct: >= $0.00Ema 20: >= -100Ema 200: >= -100Monthly Average Dollar Volume: >= -100Macd: bullish
Ticker
Name
Market Cap$
top bottom
BAND logo
BAND
Bandwidth Inc
1.44B
CTW logo
CTW
CTW Cayman
179.09M
INSG logo
INSG
Inseego Corp
329.52M
NRXS logo
NRXS
Neuraxis Inc
92.96M
NAVN logo
NAVN
Navan Inc
4.63B
STX logo
STX
Seagate Technology Holdings PLC
163.00B
what are some good small cap stocks to buy
Intellectia · 27 candidates
Market Cap: 300.00M - 2.00BBeta: ModerateRiskWeekly Average Turnover: >= 1,000,000Pe Ttm: <= 16Annual Revenue Yoy Growth: >= 25.0%
Ticker
Name
Market Cap$
top bottom
CMRE logo
CMRE
Costamare Inc
1.91B
AGIO logo
AGIO
Agios Pharmaceuticals Inc
1.58B
AESI logo
AESI
Atlas Energy Solutions Inc
1.44B
TWO logo
TWO
Two Harbors Investment Corp
1.40B
QURE logo
QURE
Uniqure NV
1.35B
IMTX logo
IMTX
Immatics NV
1.34B

Whales Holding NUTX

D
Divisadero Street Capital Management, LP
Holding
NUTX
+24.26%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Nutex Health Inc (NUTX) stock price today?

The current price of NUTX is 187.9 USD — it has decreased -2.91

What is Nutex Health Inc (NUTX)'s business?

Nutex Health Inc. is a healthcare management and operations company. The Company operates in three segments: the Hospital division, the Population Health Management (PHM) division, and the Real Estate division. The Hospital division owns, develops and operates healthcare models, including micro-hospitals, specialty hospitals, and hospital outpatient departments (HOPDs). This division owns and operates over 27 facilities in 12 states. In addition, it has financial and operating relationships with multiple professional entities and real estate entities. The Population Health Management division owns and operates provider networks, such as Independent Physician Associations (IPAs). Through its Management Services Organization, it provides management, administrative and other support services to its affiliated hospitals and physician groups. The Real Estate division comprises the Real Estate Entities, which owns the land and hospital buildings which are leased to its hospital entities.

What is the price predicton of NUTX Stock?

Wall Street analysts forecast NUTX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NUTX is265.00 USD with a low forecast of 230.00 USD and a high forecast of 300.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Nutex Health Inc (NUTX)'s revenue for the last quarter?

Nutex Health Inc revenue for the last quarter amounts to 216.49M USD, increased 2.22

What is Nutex Health Inc (NUTX)'s earnings per share (EPS) for the last quarter?

Nutex Health Inc. EPS for the last quarter amounts to 6.52 USD, increased 95.80

How many employees does Nutex Health Inc (NUTX). have?

Nutex Health Inc (NUTX) has 944 emplpoyees as of July 08 2026.

What is Nutex Health Inc (NUTX) market cap?

Today NUTX has the market capitalization of 1.29B USD.